Delaware Business DE

AstraZeneca-Daiichi Sankyo breast cancer drug shows positive results in late-stage trial

Delaware Business Now

Feb 25, 2022

AstraZeneca reported promising results from a Phase III trial showed Enhertu (trastuzumab deruxtecan) increased progression-free survival and overall survival in patients with cert…

Read the full story at Delaware Business Now

AstraZeneca-Daiichi Sankyo breast cancer drug shows positive results in late-stage trial

More from Delaware Business

Delaware charters pulled for LLC's tied to drug traffickers

Delaware gas prices approach year-ago numbers

Rack Room Shoes opens in Salisbury, and a new pool hall on the way | What's Going There

Suspect dead after carjackings, pursuit by officers in I-95 area

PBF Energy acquires remaining interests in logistics business

My take: Feds take closer look at criminal monopoly actions

ChristianaCare center named in honor of donor and breast cancer survivor Tatiana Copeland

Veteran Business Leader and Communications Specialist to Assume Role of Vice Chair